Nicholas B. Jennings

6.2k total citations
45 papers, 2.5k citations indexed

About

Nicholas B. Jennings is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Nicholas B. Jennings has authored 45 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 11 papers in Cancer Research and 10 papers in Oncology. Recurrent topics in Nicholas B. Jennings's work include Angiogenesis and VEGF in Cancer (13 papers), Cancer, Stress, Anesthesia, and Immune Response (9 papers) and Ovarian cancer diagnosis and treatment (8 papers). Nicholas B. Jennings is often cited by papers focused on Angiogenesis and VEGF in Cancer (13 papers), Cancer, Stress, Anesthesia, and Immune Response (9 papers) and Ovarian cancer diagnosis and treatment (8 papers). Nicholas B. Jennings collaborates with scholars based in United States, South Korea and China. Nicholas B. Jennings's co-authors include Anil K. Sood, Gabriel Lopez‐Berestein, Steve W. Cole, Susan K. Lutgendorf, Yvonne G. Lin, Robert L. Coleman, Guillermo N. Armaiz-Peña, Charles N. Landen, Lingegowda S. Mangala and Jesusa M.G. Arevalo and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and JNCI Journal of the National Cancer Institute.

In The Last Decade

Nicholas B. Jennings

44 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicholas B. Jennings United States 27 1.3k 718 478 439 269 45 2.5k
Guillermo N. Armaiz-Peña United States 27 1.3k 1.0× 750 1.0× 736 1.5× 603 1.4× 301 1.1× 63 2.8k
Liz Y. Han United States 25 1.7k 1.3× 1.0k 1.5× 387 0.8× 804 1.8× 347 1.3× 34 3.4k
David M. Gershenson United States 26 1.8k 1.3× 1.1k 1.5× 316 0.7× 870 2.0× 261 1.0× 31 3.4k
Luís Hernández Spain 40 1.7k 1.3× 1.5k 2.0× 368 0.8× 507 1.2× 472 1.8× 95 4.2k
Ángela Sanguino United States 15 642 0.5× 358 0.5× 183 0.4× 206 0.5× 97 0.4× 33 1.3k
Henne Holstege Netherlands 26 1.3k 1.0× 691 1.0× 219 0.5× 366 0.8× 158 0.6× 72 2.8k
Claudia A. Landis United States 11 1.2k 0.9× 412 0.6× 123 0.3× 255 0.6× 161 0.6× 13 2.5k
Anita L. Hawkins United States 31 1.9k 1.5× 707 1.0× 236 0.5× 394 0.9× 595 2.2× 62 4.0k
Kate Groot United States 44 1.5k 1.2× 1.4k 1.9× 202 0.4× 523 1.2× 780 2.9× 143 4.9k
Fabrizio Ledda Italy 26 1.0k 0.8× 144 0.2× 371 0.8× 150 0.3× 409 1.5× 61 2.3k

Countries citing papers authored by Nicholas B. Jennings

Since Specialization
Citations

This map shows the geographic impact of Nicholas B. Jennings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicholas B. Jennings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicholas B. Jennings more than expected).

Fields of papers citing papers by Nicholas B. Jennings

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicholas B. Jennings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicholas B. Jennings. The network helps show where Nicholas B. Jennings may publish in the future.

Co-authorship network of co-authors of Nicholas B. Jennings

This figure shows the co-authorship network connecting the top 25 collaborators of Nicholas B. Jennings. A scholar is included among the top collaborators of Nicholas B. Jennings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicholas B. Jennings. Nicholas B. Jennings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jennings, Nicholas B. & Andrii Matviienko. (2025). Reimagining Go-Go: Effects of Signifiers in VR Selection Techniques. 1–10.
2.
Jennings, Nicholas B., et al.. (2024). Theory of Human Tetrachromatic Color Experience and Printing. ACM Transactions on Graphics. 43(4). 1–15. 1 indexed citations
3.
Wu, Yutuan, Nicholas B. Jennings, Yunjie Sun, et al.. (2022). Targeting CCR2+ macrophages with BET inhibitor overcomes adaptive resistance to anti-VEGF therapy in ovarian cancer. Journal of Cancer Research and Clinical Oncology. 148(4). 803–821. 9 indexed citations
4.
Corvigno, Sara, Jared K. Burks, Wei Hu, et al.. (2021). Immune microenvironment composition in high-grade serous ovarian cancers based on BRCA mutational status. Journal of Cancer Research and Clinical Oncology. 147(12). 3545–3555. 6 indexed citations
5.
Mangala, Lingegowda S., Cristian Rodriguez‐Aguayo, Emine Bayraktar, et al.. (2021). Assessment of In Vivo siRNA Delivery in Cancer Mouse Models. Methods in molecular biology. 157–168. 2 indexed citations
6.
Yang, Hailing, Weiqun Mao, Cristian Rodriguez‐Aguayo, et al.. (2018). Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability. Clinical Cancer Research. 24(20). 5072–5084. 32 indexed citations
7.
Huang, Jie, Wei Hu, Limin Hu, et al.. (2016). Dll4 Inhibition plus Aflibercept Markedly Reduces Ovarian Tumor Growth. Molecular Cancer Therapeutics. 15(6). 1344–1352. 41 indexed citations
8.
Wen, Yunfei, Whitney A. Spannuth Graybill, Rebecca A. Previs, et al.. (2014). Immunotherapy Targeting Folate Receptor Induces Cell Death Associated with Autophagy in Ovarian Cancer. Clinical Cancer Research. 21(2). 448–459. 53 indexed citations
9.
Roh, Ju‐Won, Jie Huang, Wei Hu, et al.. (2014). Biologic Effects of Platelet-Derived Growth Factor Receptor α Blockade in Uterine Cancer. Clinical Cancer Research. 20(10). 2740–2750. 15 indexed citations
10.
Dalton, Heather J., Sunila Pradeep, Vianey González-Villasana, et al.. (2014). Clodronate inhibits tumor angiogenesis in mouse models of ovarian cancer. Cancer Biology & Therapy. 15(8). 1061–1067. 33 indexed citations
11.
Lee, Sun Joo, Sukhen C. Ghosh, Hee Dong Han, et al.. (2012). Metronomic Activity of CD44-Targeted Hyaluronic Acid-Paclitaxel in Ovarian Carcinoma. Clinical Cancer Research. 18(15). 4114–4121. 36 indexed citations
12.
Kloc, Małgorzata, Neelam Tejpal, Pedro O. Flores-Villanueva, et al.. (2012). Inverse relationship between TCTP/RhoA and p53/ /cyclin A/actin expression in ovarian cancer cells. Folia Histochemica et Cytobiologica. 50(3). 358–367. 18 indexed citations
13.
Park, Yun‐Yong, Sung Yun Jung, Nicholas B. Jennings, et al.. (2012). FOXM1 mediates Dox resistance in breast cancer by enhancing DNA repair. Carcinogenesis. 33(10). 1843–1853. 102 indexed citations
14.
Wang, Enfeng, Sanjib Bhattacharyya, Annamária Szabolcs, et al.. (2011). Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer. PLoS ONE. 6(3). e17918–e17918. 72 indexed citations
15.
Spannuth, Whitney A., Lingegowda S. Mangala, Rebecca L. Stone, et al.. (2010). Converging Evidence for Efficacy from Parallel EphB4-Targeted Approaches in Ovarian Carcinoma. Molecular Cancer Therapeutics. 9(8). 2377–2388. 33 indexed citations
16.
Lee, Jeong‐Won, Rebecca L. Stone, Sun Joo Lee, et al.. (2010). EphA2 Targeted Chemotherapy Using an Antibody Drug Conjugate in Endometrial Carcinoma. Clinical Cancer Research. 16(9). 2562–2570. 57 indexed citations
17.
Ahmed, Ahmed A., Zhen Lü, Nicholas B. Jennings, et al.. (2010). SIK2 Is a Centrosome Kinase Required for Bipolar Mitotic Spindle Formation that Provides a Potential Target for Therapy in Ovarian Cancer. Cancer Cell. 18(2). 109–121. 105 indexed citations
18.
Lu, Chunhua, Mian M.K. Shahzad, Myrthala Moreno‐Smith, et al.. (2010). Targeting pericytes with a PDGF-B aptamer in human ovarian carcinoma models. Cancer Biology & Therapy. 9(3). 176–182. 66 indexed citations
19.
Kim, Tae Jin, Charles N. Landen, Yvonne G. Lin, et al.. (2009). Combined anti-angiogenic therapy against VEGF and integrin alphabeta in an orthotopic model of ovarian cancer. Cancer Biology & Therapy. 8(23). 2261–2270. 16 indexed citations
20.
Spannuth, Whitney A., Alpa M. Nick, Nicholas B. Jennings, et al.. (2008). Functional significance of VEGFR‐2 on ovarian cancer cells. International Journal of Cancer. 124(5). 1045–1053. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Guillermo N. Armaiz-Peña Breakdown of academic impact, for papers by Liz Y. Han Breakdown of academic impact, for papers by David M. Gershenson Breakdown of academic impact, for papers by Luís Hernández Breakdown of academic impact, for papers by Ángela Sanguino Breakdown of academic impact, for papers by Henne Holstege Breakdown of academic impact, for papers by Claudia A. Landis Breakdown of academic impact, for papers by Anita L. Hawkins Breakdown of academic impact, for papers by Kate Groot Breakdown of academic impact, for papers by Fabrizio Ledda
Rankless by CCL
2026